Synopsis
Synopsis
0
KDMF
0
VMF
0
FDF
0
Canada
DRUG PRODUCT COMPOSITIONS
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. Chloramiphene
2. Citrate, Clomiphene
3. Clomid
4. Clomide
5. Clomifen
6. Clomifene
7. Clomiphene
8. Clomiphene Citrate
9. Clomiphene Hydrochloride
10. Clostilbegit
11. Dyneric
12. Gravosan
13. Hydrochloride, Clomiphene
14. Klostilbegit
15. Serophene
1. Clomiphene Citrate
2. 50-41-9
3. Zuclomiphene Citrate
4. Cis-clomiphene Citrate
5. Clomid
6. Zuclomid
7. Clomiphene A Citrate
8. 7619-53-6
9. Clomiphene Citrate Salt
10. Milophene
11. Serophene
12. (z)-clomiphene Citrate
13. Chloramiphene
14. Omifin
15. Rmi 16289
16. Clomivid
17. Clomphid
18. Dyneric
19. Genozym
20. Ikaclomin
21. Clomifene Citrate (serophene)
22. Zuclomiphene (citrate)
23. Uy5x264qzv
24. Mrl 41
25. Nsc-151466
26. 2-(4-(2-chloro-1,2-diphenylvinyl)phenoxy)-n,n-diethylethanamine 2-hydroxypropane-1,2,3-tricarboxylate
27. Nsc 35770
28. Rmi 16312
29. 2-[4-[(z)-2-chloro-1,2-diphenylethenyl]phenoxy]-n,n-diethylethanamine;2-hydroxypropane-1,2,3-tricarboxylic Acid
30. Ethanamine, 2-(4-((1z)-2-chloro-1,2-diphenylethenyl)phenoxy)-n,n-diethyl-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
31. Ethanamine, 2-[4-(2-chloro-1,2-diphenylethenyl)phenoxy]-n,n-diethyl-,2-hydroxy-1,2,3-propanetricarboxylate (1:1)
32. Mer-41
33. Mrl-41
34. Unii-uy5x264qzv
35. Nsc 151466
36. Nsc-35770
37. Cas-50-41-9
38. Clomiphene Citrate, Cis-
39. Triethylamine, 2-(p-(2-chloro-1,2-diphenylvinyl)phenoxy)-, Citrate (1:1), (z)-
40. Mls001332629
41. Mls002207099
42. Schembl223472
43. Spectrum1500196
44. Sgcut00109
45. Chembl1213137
46. Hms501h04
47. Hy-b1617a
48. Hms1920o19
49. Hms2091g06
50. Hms2232d12
51. Pharmakon1600-01500196
52. Amy33425
53. Bcp03057
54. To_000032
55. Ccg-39553
56. Nsc151466
57. Nsc756698
58. S2561
59. Akos005111131
60. Bcp9000541
61. Ds-6814
62. Fd12066
63. Nsc-756698
64. Ncgc00017008-01
65. Ncgc00017008-02
66. Ncgc00017008-03
67. Ncgc00094626-01
68. Ncgc00094626-02
69. Ncgc00164385-01
70. Ac-19685
71. Ac-32011
72. Ethanamine, 2-(4-(2-chloro-1,2-diphenylethenyl)phenoxy)-n,n-diethyl-, (z)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
73. Bcp0726000214
74. Cs-0111663
75. Sw196898-3
76. C08161
77. Triethylamine,2-diphenylvinyl)phenoxy]-, Citrate
78. Sr-05000001591
79. Sr-05000001591-1
80. Q27291328
81. Triethylamine,2-diphenylvinyl)phenoxy]-, Citrate (1:1)
82. Triethylamine,2-diphenylvinyl)phenoxy]-, Citrate (1:1), (z)-
83. (2)2-[p-(2-chloro-1,2-diphenylvinyl)phenoxy]triethylamine Citrate (1:1)
84. 2-(4-[2-chloro-1,2-diphenylethenyl]phenoxy)-n,n-diethylethanamine Citrate Salt
85. {2-[4-(2-chloro-1,2-diphenylvinyl)phenoxy]ethyl}diethylamine 2-hydroxypropane-1,2,3-tricarboxylic Acid Salt
86. 2-({4-[(z)-2-chloro-1,2-diphenylethenyl]phenyl}oxy)-n,n-diethylethanamine 2-hydroxypropane-1,2,3-tricarboxylate (salt)
87. Ethanamine,2-diphenylethenyl)phenoxy]-n,n-diethyl-, (z)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
88. Ethanamine,2-diphenylethenyl)phenoxy]-n,n-diethyl-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
Molecular Weight | 598.1 g/mol |
---|---|
Molecular Formula | C32H36ClNO8 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 9 |
Rotatable Bond Count | 14 |
Exact Mass | 597.2129448 g/mol |
Monoisotopic Mass | 597.2129448 g/mol |
Topological Polar Surface Area | 145 Ų |
Heavy Atom Count | 42 |
Formal Charge | 0 |
Complexity | 708 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 6 | |
---|---|
Drug Name | Clomid |
PubMed Health | Clomiphene (By mouth) |
Drug Classes | Endocrine-Metabolic Agent, Female Reproductive Agent |
Drug Label | Clomiphene citrate tablets, USP is an orally administered, nonsteroidal, ovulatory stimulant designated chemically as 2-[p-(2chloro-1,2-diphenylvinyl)phenoxy] triethylamine citrate (1:1). It has the molecular formula of C26H28CINO C6H8O7 and a mo... |
Active Ingredient | Clomiphene citrate |
Dosage Form | Tablet |
Route | Oral |
Strength | 50mg |
Market Status | Prescription |
Company | Sanofi Aventis Us |
2 of 6 | |
---|---|
Drug Name | Clomiphene citrate |
PubMed Health | Clomiphene (By mouth) |
Drug Classes | Endocrine-Metabolic Agent, Female Reproductive Agent |
Drug Label | ClomiPHENE citrate is an orally administered, nonsteroidal, ovulatory stimulant designated chemically as 2-[p-(2-chloro-1,2-diphenylvinyl) phenoxy] triethylamine citrate (1:1). It has a molecular formula of C26H28CINO C6H8O7 and a molecular weig... |
Active Ingredient | Clomiphene citrate |
Dosage Form | Tablet |
Route | Oral |
Strength | 50mg |
Market Status | Prescription |
Company | Par Pharm |
3 of 6 | |
---|---|
Drug Name | Serophene |
Active Ingredient | Clomiphene citrate |
Dosage Form | Tablet |
Route | Oral |
Strength | 50mg |
Market Status | Prescription |
Company | Emd Serono |
4 of 6 | |
---|---|
Drug Name | Clomid |
PubMed Health | Clomiphene (By mouth) |
Drug Classes | Endocrine-Metabolic Agent, Female Reproductive Agent |
Drug Label | Clomiphene citrate tablets, USP is an orally administered, nonsteroidal, ovulatory stimulant designated chemically as 2-[p-(2chloro-1,2-diphenylvinyl)phenoxy] triethylamine citrate (1:1). It has the molecular formula of C26H28CINO C6H8O7 and a mo... |
Active Ingredient | Clomiphene citrate |
Dosage Form | Tablet |
Route | Oral |
Strength | 50mg |
Market Status | Prescription |
Company | Sanofi Aventis Us |
5 of 6 | |
---|---|
Drug Name | Clomiphene citrate |
PubMed Health | Clomiphene (By mouth) |
Drug Classes | Endocrine-Metabolic Agent, Female Reproductive Agent |
Drug Label | ClomiPHENE citrate is an orally administered, nonsteroidal, ovulatory stimulant designated chemically as 2-[p-(2-chloro-1,2-diphenylvinyl) phenoxy] triethylamine citrate (1:1). It has a molecular formula of C26H28CINO C6H8O7 and a molecular weig... |
Active Ingredient | Clomiphene citrate |
Dosage Form | Tablet |
Route | Oral |
Strength | 50mg |
Market Status | Prescription |
Company | Par Pharm |
6 of 6 | |
---|---|
Drug Name | Serophene |
Active Ingredient | Clomiphene citrate |
Dosage Form | Tablet |
Route | Oral |
Strength | 50mg |
Market Status | Prescription |
Company | Emd Serono |
Fertility Agents, Female
Compounds which increase the capacity to conceive in females. (See all compounds classified as Fertility Agents, Female.)
Estrogen Antagonists
Compounds which inhibit or antagonize the action or biosynthesis of estrogenic compounds. (See all compounds classified as Estrogen Antagonists.)
Selective Estrogen Receptor Modulators
A structurally diverse group of compounds distinguished from ESTROGENS by their ability to bind and activate ESTROGEN RECEPTORS but act as either an agonist or antagonist depending on the tissue type and hormonal milieu. They are classified as either first generation because they demonstrate estrogen agonist properties in the ENDOMETRIUM or second generation based on their patterns of tissue specificity. (Horm Res 1997;48:155-63) (See all compounds classified as Selective Estrogen Receptor Modulators.)
Octavius has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 32838
Submission : 2018-06-04
Status : Active
Type : II
NDC Package Code : 10577-916
Start Marketing Date : 2014-11-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Available Reg Filing : ASMF |
Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3957
Submission : 1980-10-06
Status : Active
Type : II
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
GDUFA
DMF Review : Reviewed
Rev. Date : 2023-11-21
Pay. Date : 2023-11-17
DMF Number : 28947
Submission : 2015-01-20
Status : Active
Type : II
Certificate Number : R1-CEP 2003-251 - Rev 06
Issue Date : 2022-02-09
Type : Chemical
Substance Number : 997
Status : Valid
NDC Package Code : 10577-916
Start Marketing Date : 2014-11-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Available Reg Filing : ASMF |
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 29195
Submission : 2015-04-16
Status : Active
Type : II
NDC Package Code : 10577-916
Start Marketing Date : 2014-11-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Available Reg Filing : ASMF |
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 8728
Submission : 1990-09-07
Status : Inactive
Type : II
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
Certificate Number : R1-CEP 2003-251 - Rev 06
Status : Valid
Issue Date : 2022-02-09
Type : Chemical
Substance Number : 997
Certificate Number : R1-CEP 2003-193 - Rev 04
Status : Suspended by EDQM GMP non-compliance
Issue Date : 2020-08-07
Type : Chemical
Substance Number : 997
Date of Issue : 2022-09-07
Valid Till : 2025-07-02
Written Confirmation Number : WC-248
Address of the Firm : N-57, MIDC, Anand Nagar, Additional Ambernath, Dist. Thane-421501, Mahrashtra
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
NDC Package Code : 10577-916
Start Marketing Date : 2014-11-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
NDC Package Code : 49169-1040
Start Marketing Date : 2014-11-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
NDC Package Code : 10577-917
Start Marketing Date : 2014-11-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 71052-506
Start Marketing Date : 2022-05-04
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 82891-023
Start Marketing Date : 2024-08-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 48087-0132
Start Marketing Date : 2017-10-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 46014-1122
Start Marketing Date : 1988-11-30
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62991-2702
Start Marketing Date : 2009-05-24
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17369-817
Start Marketing Date : 1982-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 90027-025
Start Marketing Date : 2023-03-31
End Marketing Date : 2025-05-04
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
Octavius has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.
About the Company : Octavius Pharma is a global leader in Directly Compressible Granules with over 40 years of experience in Formulation development, manufacturing and commercialization. It offers a w...
About the Company : Suanfarma founded in 1993, is a B2B life science partner committed to health & innovation by developing, manufacturing, & distributing high-quality APIs for the pharmaceutical indu...
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
About the Company : Since its inception in 2003, Seqens has grown to become a global leader in pharmaceutical solutions and specialty ingredients. Seqens supports its customers in developing, scaling ...
Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.
About the Company : Egis is a member of the Servier Group. Egis’ products are manufactured at 3 production sites in Hungary, which are certified by EMA,FDA, ANVISA, PMDA ,KFDA. Egis sells its produc...
About the Company : Jai Radhe Sales was founded in 1999 as an out-of-the-box distribution firm specializing in the global supply of high-quality pharmaceutical ingredients. The firm provides complete ...
About the Company : HRV Global is a leading global manufacturer, seller & exporter of a wide range of APIs, advanced intermediates, pellets, food grade chemicals, food additives & food ingredients. It...
About the Company : Aasraw Biochemical Technology Co.,ltd was reorganized by a Shanghai based Biochemical Engineering Laboratory in 2008, which was built by 5 Chinese Ph. Doctors, who are majored at C...
About the Company : ASG Biochem Private Limited at Ganganagar near Kolkata, West Bengal, India, is a bulk API manufacturing company of the New Delhi based diversified APEEJAY STYA GROUP. The unit acqu...
About the Company : Livmore Life Sciences Pvt. Ltd., established in 2016, is a pharmaceutical company dedicated to the development, optimization, and manufacturing of high-quality Active Pharmaceutica...
About the Company : Senores Pharmaceuticals is a thought-leading pharmaceutical company all set to leave its footprints in the global market. We at Senores Pharmaceuticals are committed to innovate an...
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Enclomiphene Citrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Enclomiphene Citrate, including repackagers and relabelers. The FDA regulates Enclomiphene Citrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Enclomiphene Citrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Enclomiphene Citrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Enclomiphene Citrate supplier is an individual or a company that provides Enclomiphene Citrate active pharmaceutical ingredient (API) or Enclomiphene Citrate finished formulations upon request. The Enclomiphene Citrate suppliers may include Enclomiphene Citrate API manufacturers, exporters, distributors and traders.
click here to find a list of Enclomiphene Citrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Enclomiphene Citrate DMF (Drug Master File) is a document detailing the whole manufacturing process of Enclomiphene Citrate active pharmaceutical ingredient (API) in detail. Different forms of Enclomiphene Citrate DMFs exist exist since differing nations have different regulations, such as Enclomiphene Citrate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Enclomiphene Citrate DMF submitted to regulatory agencies in the US is known as a USDMF. Enclomiphene Citrate USDMF includes data on Enclomiphene Citrate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Enclomiphene Citrate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Enclomiphene Citrate suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Enclomiphene Citrate Drug Master File in Japan (Enclomiphene Citrate JDMF) empowers Enclomiphene Citrate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Enclomiphene Citrate JDMF during the approval evaluation for pharmaceutical products. At the time of Enclomiphene Citrate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Enclomiphene Citrate suppliers with JDMF on PharmaCompass.
A Enclomiphene Citrate CEP of the European Pharmacopoeia monograph is often referred to as a Enclomiphene Citrate Certificate of Suitability (COS). The purpose of a Enclomiphene Citrate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Enclomiphene Citrate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Enclomiphene Citrate to their clients by showing that a Enclomiphene Citrate CEP has been issued for it. The manufacturer submits a Enclomiphene Citrate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Enclomiphene Citrate CEP holder for the record. Additionally, the data presented in the Enclomiphene Citrate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Enclomiphene Citrate DMF.
A Enclomiphene Citrate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Enclomiphene Citrate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Enclomiphene Citrate suppliers with CEP (COS) on PharmaCompass.
A Enclomiphene Citrate written confirmation (Enclomiphene Citrate WC) is an official document issued by a regulatory agency to a Enclomiphene Citrate manufacturer, verifying that the manufacturing facility of a Enclomiphene Citrate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Enclomiphene Citrate APIs or Enclomiphene Citrate finished pharmaceutical products to another nation, regulatory agencies frequently require a Enclomiphene Citrate WC (written confirmation) as part of the regulatory process.
click here to find a list of Enclomiphene Citrate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Enclomiphene Citrate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Enclomiphene Citrate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Enclomiphene Citrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Enclomiphene Citrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Enclomiphene Citrate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Enclomiphene Citrate suppliers with NDC on PharmaCompass.
Enclomiphene Citrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Enclomiphene Citrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Enclomiphene Citrate GMP manufacturer or Enclomiphene Citrate GMP API supplier for your needs.
A Enclomiphene Citrate CoA (Certificate of Analysis) is a formal document that attests to Enclomiphene Citrate's compliance with Enclomiphene Citrate specifications and serves as a tool for batch-level quality control.
Enclomiphene Citrate CoA mostly includes findings from lab analyses of a specific batch. For each Enclomiphene Citrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Enclomiphene Citrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Enclomiphene Citrate EP), Enclomiphene Citrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Enclomiphene Citrate USP).
LOOKING FOR A SUPPLIER?